论文部分内容阅读
目的:探讨C-反应蛋白检测在小儿肺炎支原体肺炎中的临床应用价值。方法:我院自2011年6月至2012年6月收治肺炎支原体肺炎患儿和细菌性支气管肺炎患儿各56例,分别分为支原体肺炎组和细菌性肺炎组,对两组患儿采用酶联免疫法进行血清C-反应蛋白检测,统计两组患儿的C-反应蛋白阳性率。结果:支原体肺炎组56例患儿中,C-反应蛋白阳性6例,阴性50例,阳性率为10.71%;细菌性肺炎组56例患儿中,C-反应蛋白阳性51例,阴性5例,阳性率为91.07%。两组患儿C-反应蛋白检测阳性率比较,差异性显著。结论:C-反应蛋白检测能够指导细菌性肺炎与肺炎支原体肺炎的临床用药,且对其早期鉴别也有一定的指导意义。
Objective: To investigate the clinical application of C-reactive protein in children with Mycoplasma pneumoniae pneumonia. Methods: From June 2011 to June 2012, 56 children with mycoplasma pneumoniae pneumonia and bacterial bronchopneumonia were treated in our hospital from June 2011 to June 2012. The patients were divided into mycoplasma pneumonia group and bacterial pneumonia group respectively. Serum C-reactive protein was detected by ELISA, and the positive rate of C-reactive protein in both groups was calculated. Results: Of the 56 cases of mycoplasma pneumonia group, 6 cases were positive for C-reactive protein and 50 cases were negative, the positive rate was 10.71%. Among 56 cases of bacterial pneumonia group, C-reactive protein was positive in 51 cases and negative in 5 cases , The positive rate was 91.07%. The positive rates of C-reactive protein in both groups were significantly different. Conclusion: C-reactive protein test can guide the clinical use of bacterial pneumonia and Mycoplasma pneumoniae pneumonia, and also has some guiding significance for its early identification.